Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience-Reference-Cited by-同舟云学术

Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience

Published:2017-06 Issue:6 Volume:23 Page:945-951
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Michelis Fotios V.,Kotchetkov Rouslan,Grunwald Rebecca M.,Azeem Aamir,Atenafu Eshetu G.,Lipton Jeffrey H.,Loach David,Gupta Vikas,Kuruvilla John,Kim Dennis D.^ORCID,Viswabandya Auro,Deotare Uday,Messner Hans A.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference33 articles.

2. Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update;Mohty;Blood Cancer J,2011

3. Solid cancers after allogeneic hematopoietic cell transplantation;Rizzo;Blood,2009

4. Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies;Le;Biol Blood Marrow Transplant,2010

5. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease;Atsuta;Ann Oncol,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin Cancer in the Immunocompromised Patient;Rook's Textbook of Dermatology;2024-03-19

2. Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up;Haematologica;2023-02-02

3. Outcomes of patients with esophageal cancer after allogeneic hematopoietic stem cell transplantation;Journal of Gastrointestinal Oncology;2022-12

4. Multifocal oral squamous cell carcinoma post haematopoietic stem cell transplantation: A case report;Journal of Taibah University Medical Sciences;2022-10

5. Soins primaires pour les bénéficiaires d’allogreffe de cellules souches hématopoïétiques;Canadian Medical Association Journal;2021-02-08